Stock

Processa Pharmaceuticals, Inc.

000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol PCSA:xnas
Currency USD
united-states
NASDAQ (Small cap)
Open Closed
15 minutes delayed
Data provided by Cboe Global Markets
This information is not currently available for this instrument. Refresh the page or try again later.
Instrument Card
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.

Chart

This information is not currently available for this instrument. Refresh the page or try again later.
Open account to access more charting and analysis tools

Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.

Quotes

  • Bid
  • Ask
  • Open
  • Previous close
  • Volume
  • Relative volume
  • High
  • Low
This information is not currently available for this instrument. Refresh the page or try again later.

Returns

Year to date (YTD) -2.78%
1 year -67.06%
3 years -76.17%
Data provided by FactSet Research Systems

Key stats

Price/earnings (LTM) -
Dividend yield (LTM) -
EPS (LTM) -16.87
Volatility (30 days) 132.84%
Data provided by FactSet Research Systems

ESG risk

ESG risk score -
Environmental score -
Social score -
Governance score -
ESG risk category -
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+

ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).

Download ESG risk methodology (PDF)
Data provided by Morningstar / Sustain Analytics

Financials

Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX

About Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.

Sector Healthcare
Industry -
Market cap 0.007634315bn
Data provided by Morningstar / FactSet Research Systems

Frequently asked questions

To buy Processa Pharmaceuticals, Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Processa Pharmaceuticals, Inc. by name or ticker, choose the number of shares, and place your order.

Learn about Saxo accounts.

The ticker symbol for Processa Pharmaceuticals, Inc. is PCSA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.

Processa Pharmaceuticals, Inc. has its primary listing on NASDAQ (Small cap). You can trade Processa Pharmaceuticals, Inc. with a Saxo account, alongside thousands of other stocks worldwide.

Yes, Processa Pharmaceuticals, Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Processa Pharmaceuticals, Inc. as part of a broader investment portfolio.

Explore our SaxoInvestor platform.

Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Processa Pharmaceuticals, Inc. or others.

Saxo Bank A/S (Headquarters)
Philip Heymans Alle 15
2900 Hellerup
Denmark

Contact Saxo

International
International

All trading and investing comes with risk, including but not limited to the potential to lose your entire invested amount.

Information on our international website (as selected from the globe drop-down) can be accessed worldwide and relates to Saxo Bank A/S as the parent company of the Saxo Bank Group. Any mention of the Saxo Bank Group refers to the overall organisation, including subsidiaries and branches under Saxo Bank A/S. Client agreements are made with the relevant Saxo entity based on your country of residence and are governed by the applicable laws of that entity's jurisdiction.

Apple and the Apple logo are trademarks of Apple Inc., registered in the US and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.